Le NgocDiep T. MD, PhD 4
4 · Verastem, Inc. · Filed Jun 4, 2018
Insider Transaction Report
Form 4
Verastem, Inc.VSTM
Le NgocDiep T. MD, PhD
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2018-04-06+2,500→ 2,500 totalExercise: $2.97From: 2018-04-06Exp: 2028-01-05→ Common Stock (2,500 underlying)
Footnotes (1)
- [F1]On January 5, 2018, the Reporting Person was granted an option to purchase 12,500 shares of common stock. The option vests based on the Issuer's satisfaction of certain performance milestones by June 30, 2018, by March 31, 2019, and within the first twenty-four (24) months after the achievement of certain net sales targets. 20% of the performance criteria was met on April 6, 2018, resulting in vesting of the option as to 2,500 shares.